Literature DB >> 33459740

The role of natural products in the prevention and treatment of pulmonary fibrosis: a review.

Liqun Wang1, Sha Li2, Yuqin Yao2, Wenya Yin2, Tinghong Ye3.   

Abstract

Pulmonary fibrosis is an incurable end-stage lung disease and remains a global public health problem. Although there have been some breakthroughs in understanding the pathogenesis of pulmonary fibrosis, effective intervention methods are still limited. Natural products have the advantages of multiple biological activities and high levels of safety, which are important factors for preventing and treating pulmonary fibrosis. In this review, we summarized the mechanisms and health benefits of natural products against pulmonary fibrosis. These natural products target oxidative stress, inflammatory injury, epithelial-mesenchymal transition (EMT), fibroblast activation, extracellular matrix accumulation and metabolic regulation, and the mechanisms involve the NF-κB, TGF-β1/Smad, PI3K/Akt, p38 MAPK, Nrf2-Nox4, and AMPK signaling pathways. We hope to provide new ideas for pulmonary fibrosis prevention and treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33459740     DOI: 10.1039/d0fo03001e

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  5 in total

Review 1.  Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis.

Authors:  Cristina Estornut; Javier Milara; María Amparo Bayarri; Nada Belhadj; Julio Cortijo
Journal:  Front Pharmacol       Date:  2022-01-21       Impact factor: 5.810

Review 2.  Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis.

Authors:  Mahbub Hasan; Nidhan Chandra Paul; Shamrat Kumar Paul; Abu Saim Mohammad Saikat; Hafeza Akter; Manoj Mandal; Sang-Suk Lee
Journal:  Molecules       Date:  2022-02-22       Impact factor: 4.411

3.  Potential "Therapeutic" Effects of Tocotrienol-Rich Fraction (TRF) and Carotene "Against" Bleomycin-Induced Pulmonary Fibrosis in Rats via TGF-β/Smad, PI3K/Akt/mTOR and NF-κB Signaling Pathways.

Authors:  Yifei Lu; Yihan Zhang; Zhenyu Pan; Chao Yang; Lin Chen; Yuanyuan Wang; Dengfeng Xu; Hui Xia; Shaokang Wang; Shiqing Chen; Yoong Jun Hao; Guiju Sun
Journal:  Nutrients       Date:  2022-03-05       Impact factor: 5.717

4.  Study on the molecular mechanisms of tetrandrine against pulmonary fibrosis based on network pharmacology, molecular docking and experimental verification.

Authors:  Jie Li; Yi Wang; Rui Wang; Meng-Yu Wu; Jing Shan; Ying-Chi Zhang; Hai-Ming Xu
Journal:  Heliyon       Date:  2022-08-13

5.  MicroRNA let-7f-5p regulates PI3K/AKT/COX2 signaling pathway in bacteria-induced pulmonary fibrosis via targeting of PIK3CA in forest musk deer.

Authors:  Wei Zhao; Jianguo Cheng; Yan Luo; Wenlong Fu; Lei Zhou; Xiang Wang; Yin Wang; Zexiao Yang; Xueping Yao; Meishen Ren; Zhijun Zhong; Xi Wu; Ziwei Ren; Yimeng Li
Journal:  PeerJ       Date:  2022-10-05       Impact factor: 3.061

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.